Plasma Free Thiol Levels during Early Sepsis Predict Future Renal Function Decline.

acute kidney injury (AKI) free thiols oxidative stress reactive oxygen species (ROS) sepsis

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
19 Apr 2022
Historique:
received: 26 03 2022
revised: 14 04 2022
accepted: 16 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Sepsis is a life-threatening syndrome characterized by acute organ dysfunction due to infection. In particular, acute kidney injury (AKI) is common among patients with sepsis and is associated with increased mortality and morbidity. Oxidative stress is an important contributor to the pathogenesis of sepsis-related AKI. Plasma free thiols (R-SH) reflect systemic oxidative stress since they are readily oxidized by reactive species and thereby serve as antioxidants. Here, we aimed to assess the concentrations of serum free thiols in sepsis and associate these with major adverse kidney events (MAKE). Adult non-trauma patients who presented at the emergency department (ED) with a suspected infection were included. Free thiol levels and ischemia-modified albumin (IMA), a marker of oxidative stress, were measured in plasma at baseline, at the ward, and at three months, and one year after hospitalization. Plasma free thiol levels were lower at the ED visit and at the ward as compared to three months and one year after hospital admission (p < 0.01). On the contrary, plasma levels of IMA were higher at the ED and at the ward compared to three months and one year after hospital admission (p < 0.01). Furthermore, univariate logistic regression analyses showed that plasma free thiol levels at the ED were inversely associated with long-term renal function decline and survival at 90 days (MAKE90) and 365 days (MAKE365) (OR 0.43 per standard deviation [SD] [0.22−0.82, 95% CI], p = 0.011 and OR 0.58 per SD [0.34−0.96, 95% CI], p = 0.035, respectively). A multivariate regression analysis revealed an independent association of plasma free thiols at the ED (OR 0.52 per SD [0.29−0.93, 95% CI], p = 0.028) with MAKE365, even after adjustments for age, eGFR at the ED, SOFA score, and cardiovascular disease. These data indicate the clear role of oxidative stress in the pathogenesis of sepsis-AKI, as reflected in the lower plasma free thiol levels and increased levels of IMA.

Identifiants

pubmed: 35624664
pii: antiox11050800
doi: 10.3390/antiox11050800
pmc: PMC9137477
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Front Physiol. 2019 Apr 26;10:499
pubmed: 31080419
N Engl J Med. 2014 Apr 10;370(15):1412-21
pubmed: 24635772
Am J Respir Crit Care Med. 2000 Jun;161(6):1907-11
pubmed: 10852765
N Engl J Med. 2014 Jul 3;371(1):58-66
pubmed: 24988558
Free Radic Biol Med. 2013 Dec;65:244-253
pubmed: 23747983
N Engl J Med. 2013 Aug 29;369(9):840-51
pubmed: 23984731
Chest. 1992 Jun;101(6):1644-55
pubmed: 1303622
Trends Mol Med. 2020 Nov;26(11):1034-1046
pubmed: 32620502
Int J Mol Sci. 2021 Apr 26;22(9):
pubmed: 33925831
Pharmacol Res. 2016 Sep;111:452-458
pubmed: 27378569
J Anti Aging Med. 2003;6(4):327-34
pubmed: 15142434
Clin J Am Soc Nephrol. 2020 Mar 6;15(3):423-429
pubmed: 32075806
BMC Med. 2020 May 27;18(1):130
pubmed: 32456645
Redox Biol. 2021 Dec 9;48:102211
pubmed: 34896941
Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Nephron Clin Pract. 2014;127(1-4):89-93
pubmed: 25343828
Med Princ Pract. 2006;15(4):322-4
pubmed: 16763404
Front Biosci. 2008 May 01;13:5030-41
pubmed: 18508567
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Curr Top Cell Regul. 2000;36:151-80
pubmed: 10842751
J Infect Dis. 2002 Apr 15;185(8):1115-20
pubmed: 11930321
Crit Care Med. 2011 Feb;39(2):386-91
pubmed: 21248514
Antioxidants (Basel). 2020 Nov 16;9(11):
pubmed: 33207555
Antioxidants (Basel). 2021 Dec 20;10(12):
pubmed: 34943125
Front Physiol. 2021 Aug 06;12:682877
pubmed: 34447316
Crit Care Med. 2009 Jul;37(7):2155-9
pubmed: 19487947
PLoS One. 2021 Aug 11;16(8):e0255930
pubmed: 34379701
Infect Disord Drug Targets. 2009 Aug;9(4):376-89
pubmed: 19689380
Mech Ageing Dev. 2011 Apr;132(4):141-8
pubmed: 21335026
Liver Int. 2015 Feb;35(2):335-43
pubmed: 24620819
Redox Biol. 2018 Jun;16:359-380
pubmed: 29627744
Lancet. 2018 Jul 7;392(10141):75-87
pubmed: 29937192
Mitochondrion. 2004 Sep;4(5-6):729-41
pubmed: 16120428
J Pharm Biomed Anal. 2014 Mar;91:17-23
pubmed: 24434278
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):339-342
pubmed: 29070523
J Clin Transl Endocrinol. 2019 Feb 28;16:100182
pubmed: 30899672
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
N Engl J Med. 2004 Jul 8;351(2):159-69
pubmed: 15247356
J Clin Med. 2019 Dec 24;9(1):
pubmed: 31878321
Liver Int. 2020 Sep;40(9):2148-2159
pubmed: 32558346
Oxid Med Cell Longev. 2018 Mar 25;2018:2353128
pubmed: 29765492
J Lab Clin Med. 1993 Feb;121(2):257-62
pubmed: 8381845
J Med Syst. 2016 Jul;40(7):167
pubmed: 27234478
J Emerg Med. 2000 Nov;19(4):311-5
pubmed: 11074321
Crit Care Med. 1996 Jul;24(7):1179-83
pubmed: 8674332
Antioxid Redox Signal. 2017 Oct 1;27(10):684-712
pubmed: 28398072
Antioxidants (Basel). 2019 Sep 01;8(9):
pubmed: 31480545
Intensive Care Med. 2017 Jun;43(6):816-828
pubmed: 28364303
N Engl J Med. 2013 Nov 21;369(21):2062-3
pubmed: 24256392

Auteurs

Elisabeth C van der Slikke (EC)

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Lisanne Boekhoud (L)

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Arno R Bourgonje (AR)

Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Tycho J Olgers (TJ)

Department of Internal Medicine, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Jan C Ter Maaten (JC)

Department of Internal Medicine, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Robert H Henning (RH)

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Harry van Goor (H)

Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Hjalmar R Bouma (HR)

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Classifications MeSH